MetaVia Inc

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About MetaVia Inc
MetaVia Inc is a clinical-stage biotechnology company focused on developing treatments for liver-related cardiometabolic diseases. Its product pipeline includes DA-1726, an oxyntomodulin analogue that acts as a dual GLP-1 and glucagon receptor agonist, being developed for metabolic and alcohol-associated liver diseases. The company is also developing vanoglipel (DA-1241), a GPR119 agonist, in combination with resmetirom for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
Frequently asked questions
To buy MetaVia Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MetaVia Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MetaVia Inc is MTVA. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MetaVia Inc has its primary listing on NASDAQ (Small cap). You can trade MetaVia Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MetaVia Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include MetaVia Inc as part of a broader investment portfolio.